Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer
BMS-986365 (CC-94676) 是一种双重雄激素受体配体导向降解剂和拮抗剂,在既往接受过大量治疗的转移性去势抵抗性前列腺癌患者中的安全性和临床活性
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2024.09.005
Rathkopf, D E; Patel, M R; Choudhury, A D; Rasco, D; Lakhani, N; Hawley, J E; Srinivas, S; Aparicio, A; Narayan, V; Runcie, K D; Emamekhoo, H; Reichert, Z R; Nguyen, M H; Wells, A L; Kandimalla, R; Liu, C; Suryawanshi, S; Han, J; Wu, J; Arora, V K; Pourdehnad, M; Armstrong, A J
肿瘤
肿瘤免疫
信号转导
多发性硬化症
前列腺癌
免疫/内分泌